Annual Meeting of Shareholders to be Reconvened on May 29, 2008
SILVER SPRING, Md., May 1 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) (the Company) held its annual meeting of shareholders (the Annual Meeting) on April 29, 2008. The Company's shareholders voted to approve the election of Raymond Dwek, Roger Jeffs and Christopher Patusky as Class III directors with terms expiring in 2011. The Company's shareholders also voted to approve the ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2008.
Following these votes, the Annual Meeting was adjourned and will be reconvened on May 29, 2008 to consider one remaining item of business: the adoption of the 2008 United Therapeutics Corporation Equity Incentive Plan (the 2008 Plan). The meeting was adjourned in order to allow shareholders time to consider a proposed amendment to the 2008 Plan (as so amended and restated, the Amended 2008 Plan).
The amendments reflected in the Amended 2008 Plan as compared with the
original plan are summarized as follows:
Amendments Proposed Under the Amended Under the Original
2008 Plan 2008 Plan
Shares of common stock reserved
for grants 1,500,000 7,000,000
Final date for granting awards December 31, 2011 10 years after
The ability to buy back awards Requires Allowed
or exchange them for other shareholder
|SOURCE United Therapeutics Corporation|
Copyright©2008 PR Newswire.
All rights reserved